Centralised procedures (CP) enable the authorisation of a pharmaceutical in the entire European Economic Area.

Noncentralised (decentralised (DCP), mutual recognition (MRP) and national) procedures are used to obtain national authorisation in one or more countries

• Data management and statistical analysis
• Medical Documentation in context of clinical trials or authorisation procedures of pharmaceuticals in compliance of the CP, MRP und DCP procedures (Common Technical Document (CTD))
• Creation of dossiers for the benefit assessment by the German Federal Joint Committee (G-BA), HTA (Health Technology Assessment)